Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
1999-2-23
pubmed:abstractText
Lucigenin has been widely used as a chemiluminescent substrate to monitor vascular superoxide (O*-2) formation. The validity of lucigenin for detection of O*-2 has been questioned because O*-2 is generated by lucigenin itself. It has been shown that the concentration of lucigenin is a critical parameter affecting the validity of this assay. In the present studies we evaluated a reduced concentration of lucigenin (5 microM) as a tool to quantify O*-2 production in vascular tissue. Lucigenin-induced effects on endothelial function were assessed by isometric tension recording of isolated aortic rings suspended in organ baths. The effects of lucigenin on O*-2 production were studied using spin trapping and electron spin resonance spectroscopy. Lucigenin at 250 microM but not at 5 microM caused a significant attenuation of endothelium-dependent relaxations to acetylcholine, which was prevented by pretreatment with superoxide dismutase. Spin-trapping studies revealed that lucigenin at 250 microM increased vascular O*-2 production several fold while 5 microM lucigenin did not stimulate O*-2 production. Inhibition of NO synthase by NG-momomethyl-l-arginine as well as the removal of the endothelium almost doubled lucigenin-derived chemiluminescence (LDCL), indicating that basal production of endothelium-derived NO depresses the baseline chemiluminescence signal. Thus, lucigenin at a concentration of 5 microM seems to be a sensitive and valid probe for assessing O*-2 in vascular tissue. It can also be used as an indirect probe to estimate basal vascular NO release.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jan
pubmed:issn
0006-291X
pubmed:author
pubmed:copyrightInfo
Copyright 1999 Academic Press.
pubmed:issnType
Print
pubmed:day
19
pubmed:volume
254
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
319-24
pubmed:dateRevised
2011-11-17
pubmed:meshHeading
pubmed-meshheading:9918836-Acetylcholine, pubmed-meshheading:9918836-Acridines, pubmed-meshheading:9918836-Animals, pubmed-meshheading:9918836-Aorta, pubmed-meshheading:9918836-Electron Spin Resonance Spectroscopy, pubmed-meshheading:9918836-Endothelium, Vascular, pubmed-meshheading:9918836-Hypercholesterolemia, pubmed-meshheading:9918836-Luminescent Measurements, pubmed-meshheading:9918836-Muscle, Smooth, Vascular, pubmed-meshheading:9918836-Nitric Oxide, pubmed-meshheading:9918836-Pentetic Acid, pubmed-meshheading:9918836-Rabbits, pubmed-meshheading:9918836-Reproducibility of Results, pubmed-meshheading:9918836-Scintillation Counting, pubmed-meshheading:9918836-Superoxide Dismutase, pubmed-meshheading:9918836-Superoxides, pubmed-meshheading:9918836-Vasodilation, pubmed-meshheading:9918836-omega-N-Methylarginine
pubmed:year
1999
pubmed:articleTitle
Validation of lucigenin as a chemiluminescent probe to monitor vascular superoxide as well as basal vascular nitric oxide production.
pubmed:affiliation
Division of Cardiology, Department of Internal Medicine, University Hospital Eppendorf, Hamburg, Germany.
pubmed:publicationType
Journal Article, In Vitro, Research Support, Non-U.S. Gov't